Bezdek Trevor 4
Research Summary
AI-generated summary
GoodRx Director Trevor Bezdek Receives 73,434 RSU Award
What Happened
- Trevor Bezdek, a director of GoodRx Holdings, Inc. (GDRX), received an award of 73,434 restricted stock units (RSUs) on 2026-06-16. The RSUs were granted at $0.00 (no cash paid at grant).
- Each RSU represents a contingent right to one share of Class A common stock; the units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 or (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Bezdek’s continued service through the vesting date.
Key Details
- Transaction date: 2026-06-16; Transaction type: Award/Grant (code A); Grant price: $0.00.
- Shares granted: 73,434 RSUs (each convertible into one Class A share upon vesting).
- Filing: Report filed 2026-06-17 (timely; not flagged as late).
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Relevant footnotes:
- F1: RSU vesting terms (see above).
- F2–F5: References to shares held in various grantor retained annuity trusts (GRATs); Bezdek serves as trustee/annuitant for certain trusts, while some trusts are held by his spouse, with disclaimers of beneficial ownership as stated in the filing.
Context
- This is an equity award (compensation/retention grant), not an open-market purchase or sale. Such grants are routine for directors and reflect compensation rather than an immediate market bet; value is realized only if/when RSUs vest and convert to shares.
- No sale or exercise occurred here; there is no immediate cash proceeds or tax-withholding sale reported in this transaction.